{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:50:30Z","timestamp":1791532230585,"version":"4.3.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>\n            Blood pressure\u2013lowering drugs have different blood pressure\u2013lowering profiles. We studied if differences in blood pressure mean and variability can explain the differences in risks of cardiovascular events and death among 15 245 high-risk hypertensive patients randomized to valsartan or amlodipine and followed for 4.2 years in the VALUE trial (Valsartan Antihypertensive Long-Term Use Evaluation). We selected patients with \u22653 visits and performed Cox regression analyses, defining mean blood pressure as a time-dependent covariate and visit-to-visit and within-visit blood pressure variability as the SD. Of 14 996 eligible patients, participants in the valsartan group had higher systolic mean blood pressure by 2.2 mm Hg, higher visit-to-visit systolic variability by 1.4 mm Hg, and higher within-visit systolic variability by 0.2 mm Hg (\n            <jats:italic>P<\/jats:italic>\n            values &lt;0.0001). The higher risks of myocardial infarction and stroke in the valsartan group was attenuated after adjustment for mean and variability of systolic blood pressure, from HR 1.19 (95% CI, 1.02\u20131.39) to 1.11 (0.96\u20131.30) and from HR 1.13 (0.96\u20131.33) to 1.00 (0.85\u20131.18), respectively. The lower risk of congestive heart failure in the valsartan group was accentuated after adjustment, from HR 0.86 (0.74\u20131.00) to 0.76 (0.65\u20130.89). A smaller effect was seen on risk of death, from 1.01 (0.92\u20131.12) to 0.94 (0.85\u20131.04). In conclusion, the higher risks of myocardial infarction and stroke in patients randomized to valsartan versus amlodipine were related to the drugs\u2019 different blood pressure modulating profiles. The risk of congestive heart failure with valsartan was lower, independent of the less favorable blood pressure modulating profile.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.119.14443","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T09:00:28Z","timestamp":1587978028000},"page":"1584-1592","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Blood Pressure\u2013Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel Blockers"],"prefix":"10.1161","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-2798","authenticated-orcid":false,"given":"Maria H.","family":"Mehlum","sequence":"first","affiliation":[{"name":"From the Department of Geriatric Medicine (M.H.M., T.B.W.), Oslo University Hospital Ullevaal, Oslo, Norway"},{"name":"Institute of Clinical Medicine (M.H.M., S.E.K., T.B.W.), University of Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Liest\u00f8l","sequence":"additional","affiliation":[{"name":"Department of Informatics (K.L.), University of Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre E.","family":"Kjeldsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology (S.E.K., E.B.), Oslo University Hospital Ullevaal, Oslo, Norway"},{"name":"Institute of Clinical Medicine (M.H.M., S.E.K., T.B.W.), University of Oslo, Norway"},{"name":"Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (S.E.K., S.J.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torgeir B.","family":"Wyller","sequence":"additional","affiliation":[{"name":"From the Department of Geriatric Medicine (M.H.M., T.B.W.), Oslo University Hospital Ullevaal, Oslo, Norway"},{"name":"Institute of Clinical Medicine (M.H.M., S.E.K., T.B.W.), University of Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevo","family":"Julius","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (S.E.K., S.J.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Rothwell","sequence":"additional","affiliation":[{"name":"Stroke Prevention Research Unit, Nuffield Department of Clinical Neuroscience, John Radcliffe Hospital, University of Oxford, United Kingdom (P.M.R.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mancia","sequence":"additional","affiliation":[{"name":"Policlinico di Monza, Monza, Italy (G.M.)"},{"name":"University of Milano-Bicocca, Milan, Italy (G.M., G.P.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[{"name":"University of Milano-Bicocca, Milan, Italy (G.M., G.P.)"},{"name":"Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital, Milan, Italy (G.P.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, State University of New York, Downstate College of Medicine (M.A.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eivind","family":"Berge","sequence":"additional","affiliation":[{"name":"Department of Cardiology (S.E.K., E.B.), Oslo University Hospital Ullevaal, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1665"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000614"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000848"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01225-8"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011489"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60108-1"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.37.2.250"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70066-1"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60235-8"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2017.05.006"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12165"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2014.02.004"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-016-0680-3"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12290"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx760"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60308-X"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4098"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2803"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09714"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx250"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000028"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.054"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10087"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16456-8"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)11911-8"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3181d5e411"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67186-3"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000039288.86470.dd"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9150(01)00729-8"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000378"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00581.x"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.201400"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31326-5"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12005"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy825"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy595"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.107565"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025301"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.029351"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.119.14443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:05:57Z","timestamp":1715594757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.119.14443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.119.14443"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.119.14443","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"2019-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}